Short sellers ramped up bets against AMCR by 22% over the past month. Cost to borrow jumped 43% as utilisation hit 39%, approaching the 52-week high.
Short interest stands at 36.0 million shares as of April 23, representing 1.56% of free float. The position climbed 22% over the past month and 3.0% in the past week. Days to cover sits at 9.0 according to FINRA data. Cost to borrow rose to 0.58%, up 22% week-over-week and 43% over the past month. Utilisation reached 38.83%, nearing the 52-week peak of 41.13%. The steady build in short interest and rising borrow costs suggest growing conviction among bears heading into the April 28 print.
Put-call ratio reached 0.56 on April 24, above the 20-day mean of 0.45. The z-score of 1.30 indicates elevated put demand relative to recent norms. PCR sits well off the 52-week high of 0.98 but climbed from near-zero levels in late March. The shift toward defensive positioning coincides with the 7.1% stock decline over the past week.
Consensus stands at Buy with 7 Buy-rated analysts covering the stock. The mean price target of $50.22 implies 29% upside from the current $38.95 close. Truist Securities lowered its target to $50 from $60 on April 15 while maintaining a Buy rating. Deutsche Bank initiated coverage with a Buy and $50 target on April 1. Wells Fargo downgraded to Equal-Weight from Overweight on March 20, cutting its target to $43 from $48. Citigroup raised its Neutral-rated target to $54 in February. Wells Fargo had previously lifted its Overweight target to $48 in January.
P/E of 9.76 contracted 0.20 points over the past month. EV/EBITDA sits at 8.62, down 0.11 over 30 days. Price-to-book fell to 1.55, sliding 0.09 over the past week. The company ranks in the 97th percentile on dividend score and 60th percentile on 12-month forward EPS growth. EPS momentum scores are weaker: 29th percentile over 30 days and just 10th percentile over 90 days. Short score rank sits at the 3rd percentile.
Insiders sold $2.5 million net over the past 90 days, with multiple executives selling into the February strength. Eaton Vance Management boosted its stake by 12.3 million shares as of March 31. Capital Research added 2.4 million shares. BlackRock, State Street, and Vanguard increased positions modestly. Wellington Management added 3.7 million shares in Q4.
AMCR reported earnings on February 3–4, 2026, following an October 2025 announcement. The stock traded near $48 in late February before sliding 19% into the current print.
No active ORTEX Alpha signals at present.
See the live data behind this article on ORTEX.
Open AMCR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
